Skip to main content
Equibles

Qube Research & Technologies Ltd

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1729829 LONDON, X0
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$22,081,468
+$2,621,489 QoQ
Shares Held
592,473
+1.4% QoQ
Ownership
0.614%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#34
of 286 holders
Holding Since
Mar 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. IDYA ranks #28 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 798,715 $240,437,176
2 INSM
INSMED Inc
 1,682,334 $179,370,451
3 REGN
Regeneron Pharmaceuticals, Inc.
 221,607 $138,180,828
4 ROIV
Roivant Sciences Ltd.
 3,454,496 $122,254,613
5 AXSM
Axsome Therapeutics, Inc.
 426,336 $104,354,262
6 APGE
Apogee Therapeutics, Inc.
 659,678 $87,559,060
7 TVTX
Travere Therapeutics, Inc.
 1,443,230 $81,989,896
8 RPRX
Royalty Pharma plc
 1,412,112 $79,177,119

All Filings in IDYA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,081,468 592,473
2026-03-31 $19,459,979 584,033
2025-12-31 $16,173,609 467,851
2025-09-30 $7,175,086 263,693
2025-06-30 $11,053,955 525,878
2025-03-31 $16,205,307 989,335
2024-12-31 $19,528,993 759,883
2024-09-30 $20,262,813 639,609
2024-06-30 $13,631,527 388,252
2024-03-31 $2,655,398 60,515
2023-12-31 $2,758,019 77,516
2023-09-30 $953,850 35,354
2023-06-30 $1,733,313 73,758
2023-03-31 $387,089 28,193
2022-03-31 $546,497 48,838